What's Next? Five Things To Look Out For In July
Key Viatris Action Anticipated; More Remdesivir Generics On The Way
In the month ahead, Mylan and Upjohn will at last begin to make final preparations for their proposed combination while second-quarter results are expected from large cap companies including Novartis’ Sandoz, Amgen, Biogen and Pfizer.
